本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NEWAMSTERDAM PHARMA CO NV

21.16
-1.2000-5.37%
盤後22.040.8800+4.16%19:59 EDT
成交量:173.29萬
成交額:3,698.90萬
市值:25.29億
市盈率:-9.87
高:22.62
開:22.32
低:21.08
收:22.36
52周最高:42.21
52周最低:21.08
股本:1.20億
流通股本:9,251.29萬
量比:0.75
換手率:1.87%
股息:- -
股息率:- -
每股收益(TTM):-2.1442
每股收益(LYR):-1.7211
淨資產收益率:-36.81%
總資產收益率:-20.11%
市淨率:4.01
市盈率(LYR):-12.29

資料載入中...

2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/18

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/18

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/18

重要事件披露

Form 8-K - Current report
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/09

重要事件披露

Form 8-K - Current report
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/05

重要事件披露

Form 8-K - Current report
2025/11/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities